This webinar will cover the Cancer Avatar Project at the California Pacific Medical Center Research Institute (CPMCRI), and Swift Biosciences’ technology that helps to overcome the complexity of tumor profiling, namely the company’s Accel-Amplicon NGS sequencing workflow.
August 15, 2018
Sponsored by
Swift Biosciences
The Cancer Avatar Project: Using Targeted NGS to Analyze Circulating Tumor DNA
GenomeWebinar
Join or Log in for Access
This content is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.
Sponsored by
